2023.04.13 Event SONIRE’s Clinical Trial Protocol for HIFU therapy in Pancreatic Cancer to be Presented at ISTU2023
2023.01.31 Press release Announcement of First Patient Enrolled in a Randomized Phase 2 study of SONIRE’s Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan
2022.03.22 Event As a result of Tohoku-Israel Startup Global Challenge Program, Tohru Satoh, President & CEO of SONIRE Therapeutics Inc., will participate in a panel discussion and startup pitch.
2021.12.22 Promotion Services Selected as a member for the Bio / Healthcare course of the Startup City Acceleration Program promoted by the Japan External Trade Organization
